Global Epigenetic Market Size, Status and Forecast 2018-2025

SKU ID :QYR-12214946 | Published Date: 29-Aug-2018 | No. of pages: 91
This report focuses on the global Epigenetic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Epigenetic development in United States, Europe and China.

Epigenetics is the study of heritable phenotype changes that do not involve alterations in the DNA sequence.
The global market for epigenetic device market is expected to be driven by the advancement in technology. The key drivers of the market are the increasing cases prevalence of cancer, growing ageing population and increase in obese population.
United States will continue to dominate the Epigenetic market for due to high availability of funding for research.
The growing government initiatives and increasing number of Biotechnology and Biopharmaceutical companies in APAC is also driving the market of epigenetic in APAC.
In 2017, the global Epigenetic market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study
Illumina
Qiagen
Abcam
Merck & Co
Sigma-Aldrich
New England Biolabs
Thermo Fisher Scientific
Diagenode
Active Motif
Roche Diagnostics
Eisai
Novartis

Market analysis by product type
DNA modifying Enzymes
RNA modifying Enzymes
Protein Modifying Enzymes

Market analysis by market
Academic Research Institutes
Biotechnology Companies
Biopharmaceutical Companies
Diagnostic Companies
Contract Research Organizations

Market analysis by Region
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Epigenetic status, future forecast, growth opportunity, key market and key players.
To present the Epigenetic development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Epigenetic are as follows:
History Year: 2017-2018
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
  • PRICE
  • $3900
    $7800
    Buy Now

Our Clients